Johnson & Johnson
J&J Buys Auris for $3B in Surgical Robotics Play
The deal is J&J's biggest move into surgical robotics, which "has been a gap for its medical device business."
J&J Gets Boost From Strong Cancer Drug Sales
The company's Q3 earnings beat estimates but "it remains too early to call for a broad recovery" in the medical-device and consumer businesses.
Why You Should Bring Customers to the M&A Table
Deal-makers often don’t consider customers, according to a global branding consultancy. When they do, everybody wins.
Will New Tax Law Uproot Overseas Financial Structures?
The TCJA may force some U.S. companies to reconsider their strategy of shifting profits to affiliates in low-tax jurisdictions.
CFOs on the Move: Week Ending March 23
Johnson & Johnson, Heidrick & Struggles, Amblin Partners, Bruker, Computer Services, Rogers, Outfront Media, LGS Innovations, True Temper Sports
J&J’s Dominic Caruso to Step Down as CFO
The company's longest-serving finance chief, who presided over three of its largest acquisitions, will be replaced by investor relations VP Joseph Wolk.
Feds Should Break Up Amazon
Amazon's dominance in a growing array of marketplaces could have catastrophic effects.
J&J, Aetna CEOs Hit Fee-for-Service System
The chief executives of two health-care giants want the industry to move further toward payments based on quality of care.
Finance Chiefs Praise Deloitte’s CFO Academy
Participants and the CFOs who send them to the program express passion for the development of future finance leaders.
What Makes for a Public-Company CFO?
Five top finance chiefs tell how they got where they are, and what their potential successors need to do.
J&J Posts $17.7B in Revenue, Misses Estimates
Tepid growth in pharmaceuticals and consumer products held back first-quarter sales but the company is still confident it will meet its full-year guidance.